1 / 0

Rosti Medical Plastics

Rosti Medical Plastics. The Hard- Plas Process. Contents. The Business Case The Hard- Plas Process Opportunities and Threats Additional Factors. The Business Case. What we seek. Funding next phase of development £500,000 across 12-18 months Technical feasibility confirmed

garron
Download Presentation

Rosti Medical Plastics

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. RostiMedical Plastics

    The Hard-Plas Process
  2. Contents The Business Case The Hard-Plas Process Opportunities and Threats Additional Factors
  3. The Business Case

  4. What we seek Funding next phase of development £500,000 across 12-18 months Technical feasibility confirmed Commercial viability sought Mass manufacture of tools for scalpels Outsourced manufacture of tool
  5. Destination of funding
  6. Destination of funding 90% directly on research 10% on ancillaries Consumer acceptance trails Publicity Transport Other – e.g. Legal
  7. Justification Tailored solution Better for client More business for Rosti IP of Hard-Plas process protected Service contracts Predictable income Company Image
  8. Justification Healthcare equipment supply industry Highly competitive Self funded future New products, such as hypodermic needles Self promoted Good brand image Diversification Begin in medical industry Expand as needs identified
  9. The Hard-Plas Process

  10. Why was this process developed? Steel scalpels have two main problems Risk of contamination when re-used Dangers post-use due to sharp edge Disposable steel scalpel Expensive and second problem remains
  11. Post-use dangers
  12. Why was this process developed? Steel scalpels have two main problems: Risk of contamination when re-used Dangers post-use due to sharp edge Disposable steel scalpel Expensive and second problem remains Polymer scalpel could be rendered safe using ‘hot plate disposal’ BUT scalpel requires sharp edges and high hardness
  13. How does Hard-Plas work ScCO2 and methanol Vacuum TEOS and water Drain/dry
  14. Benefits of Hard-Plas Achieve hardness in a polymer that is equivalent to steel (178 Brinell) Produce parts with edge radii of 150nm Post processing options if required Can produce a polymer scalpel Eliminates risk of contamination Removes the hazards of disposal
  15. Additional Factors

  16. Manufacture Currently the manufacturing capacity of the Hard-Plas polymer scalpel is minimal Mass Manufacture For the process to become viable for mass production, the manufacturing technology must be developed further on a large-scale Develop work holding for large batches; ensuring there is no compromise in quality
  17. Sterilisation After the manufacturing process the surgical instruments must be sterilised and packaged, whilst ensuring they remain sterile until use ISO 13485:2003 is the standards certification concerned with the production, assembly, packaging and sterilisation of medical devices. Once the mass manufacture process has been developed for the Hard-Plas scalpel, along with a sterilisation and packaging system; it can then be applied for other developments accordingly
  18. Consumer Perception Scalpels are traditionally manufactured using metals; and conform to the requirements of British Standard BS 2982:1992 Consumer perception of using polymer scalpels could inhibit the success of the Hard-Plas process in the medical area Why? The advantage of reducing the cross contamination risk associated with re-usable traditional scalpels is clear But the actual performance and dependability of a hardened polymer scalpel will be a matter of debate amongst practitioners and patients
  19. British Standards Secure certification of BS 2982:1992 Rosti Medical Plastics are confident of approval; the process achieves a surface hardness of at least 178 Brinell (7 Mohs) Accreditation from the BSI will help dispel any reservations on the quality and dependability of disposable plastic scalpels
  20. Consumer Acceptance Trials To demonstrate the effectiveness of the process and the performance of the polymer scalpels, consumer acceptance trials will be offered It is also hoped that the trials will be published in medical journals; to add further credibility to the Hard-Plas process in medical application Once the issue of consumer perception is addressed, it becomes a simpler process of integrating Hard-Plas process into different areas of application For example polymer hypodermic needles
  21. Opportunities and Threats

  22. Medical Equipment Industry Growing 5% a year Growth will continue Highly competitive Highly differentiated products
  23. Investment Return 2 year payback period 50% ROCE in 3 years Equipment and product sales Service contracts
  24. Timescales Hard-Plas Scalpel in Market Hard-Plas Scalpel Development Hard-Plas Needle in Market Hard-Plas Needle Development 3 Years 1 Year 2 Years
  25. Threats Medical approval General legislation Competition Environment Viability Currently feasible
  26. Future Developments in medical equipment industry Working with other clients Other applications for Hard-Plas In collaboration with other Rosti Divisions
  27. Conclusion Request £500,000 over 12-18months Return 50% ROCE in 3 Years Reason Mass manufacture Reduce risks Patients and staff Future growth potential
More Related